Washington, DC –(ENEWSPF)—June 22, 2015. Today, Representative Earl Blumenauer (OR-03) welcomed the decision of the U.S. Department of Health and Human Services (HHS) to eliminate its Public Health Service (PHS) Review Committee for non-federally funded medical marijuana research – an additional review process not applied to other Schedule I substances. Last year, Representative Blumenauer led a letter, signed by 29 other members of Congress, to the Secretary of HHS Sylvia Mathews Burwell requesting that this PHS process be eliminated.
“Today’s decision by HHS is a significant step toward improving an antiquated system that unfairly targets marijuana above and beyond other substances in research. I applaud the Administration in heeding our request and the request of many to eliminate this barrier. I hope this action will facilitate easier access to marijuana for medical researchers,” said Representative Blumenauer. “Considering the widespread use of medical marijuana, it is absolutely essential that we allow doctors and scientists to research the therapeutic benefits and risks of its use. There is still more to be done to ensure this happens. I am working on legislation to address these issues, and I look forward to working with the Administration and my colleagues in Congress to further increase research.